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Hospital Readmission of Adolescents and Young Adults
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Abstract

Key Points

IMPORTANCE Adolescents and young adults (AYA) who have complex chronic disease (CCD) are a
growing population that requires hospitalization to treat severe, acute health problems. These
patients may have increased risk of readmission as demands on their self-management increase and
as they transfer care from pediatric to adult health care practitioners.

Question How do readmission rates
vary across complex chronic disease for
adolescents and young adults with
increasing age?
Findings In this cross-sectional study of

OBJECTIVE To assess variation across CCDs in the likelihood of readmission for AYA with

215 580 adolescents and young adults

increasing age.

hospitalized for treatment of complex
chronic diseases (cystic fibrosis, type 1

DESIGN, SETTING, AND PARTICIPANTS Retrospective 1-year cross-sectional study of the 2014

diabetes, inflammatory bowel disease,

Agency for Healthcare Research and Quality Nationwide Readmissions Database for all US hospitals.

spina bifida, or sickle cell anemia),

Participants were 215 580 hospitalized individuals aged 15 to 30 years with cystic fibrosis (n = 15 213),

30-day hospital readmission rates varied

type 1 diabetes (n = 86 853), inflammatory bowel disease (n = 48 073), spina bifida (n = 7819), and

significantly across disease categories.

sickle cell anemia (n = 57 622) from January 1, 2014, to December 1, 2014.

As age increased from 15 to 30 years,
unadjusted, 30-day, unplanned hospital
readmission rates increased significantly

EXPOSURES Increasing age at index admission.

for all complex chronic disease cohorts.

MAIN OUTCOMES AND MEASURES Unplanned 30-day hospital readmission. Readmission odds
were compared by patients’ ages in 2-year epochs (with age 15-16 years as the reference) using
logistic regression, accounting for confounding patient characteristics and data clustering by
hospital.

Meaning Further attention is needed to
hospital discharge care, selfmanagement, and prevention of
readmission in adolescents and young
adults with complex chronic disease.

RESULTS Of 215 580 participants, 115 982 (53.8%) were female; the median (interquartile range)
age was 24 (20-27) years. Across CCDs, multimorbidity was common; the percentages of index
hospitalizations with 4 or more coexisting conditions ranged from to 33.4% for inflammatory bowel
disease to 74.2% for spina bifida. Thirty-day hospital readmission rates varied significantly across
CCDs: 20.2% (cystic fibrosis), 19.8% (inflammatory bowel disease), 20.4% (spina bifida), 22.5%

+ Supplemental content
Author affiliations and article information are
listed at the end of this article.

(type 1 diabetes), and 34.6% (sickle cell anemia). As age increased from 15 to 30 years, unadjusted,
30-day, unplanned hospital readmission rates increased significantly for all 5 CCD cohorts. In
multivariable analysis, age trends in the adjusted odds of readmission varied across CCDs. For
example, for AYA who had cystic fibrosis, the adjusted odds of readmission increased to 1.9 (95% CI,
1.5-2.3) by age 21 years and remained elevated through age 30 years. For AYA who had type 1
diabetes, the adjusted odds of readmission peaked at ages 23 to 24 years (odds ratio, 2.3; 95% CI,
2.1-2.6) and then declined through age 30 years.
CONCLUSIONS AND RELEVANCE These findings suggest that hospitalized AYA who have CCDs
have high rates of multimorbidity and 30-day readmission. The adjusted odds of readmission for AYA
(continued)
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Abstract (continued)

varied significantly across CCDs with increasing age. Further attention is needed to hospital discharge
care, self-management, and prevention of readmission in AYA with CCD.
JAMA Network Open. 2019;2(7):e197613. doi:10.1001/jamanetworkopen.2019.7613

Introduction
Adolescents and young adults (AYA) with complex chronic disease (CCD) are a growing population
who experience severe, acute health problems.1-3 Examples of CCD include cystic fibrosis, type 1
diabetes, inflammatory bowel disease (IBD), sickle cell anemia, and spina bifida. Aging from
adolescence to adulthood is an important process of AYA who have a CCD. As their age increases,
many AYA who have a CCD may experience progression of disease, with new or worsening existing
or coexisting illness and increased functional impairment.4,5 This fragile health status may lead to
acute health problems, including infections and chronic condition exacerbations.
Hospitalization of AYA who have a CCD may be required for treatment of acute problems and
for support during recovery from illness or procedures. Hospital discharge can be a vulnerable time
for AYA who have a CCD, depending on their age and stage of transition to adulthood. For example,
AYA with newly acquired autonomy and/or less familial support as they age may not fully appreciate
the importance of medication adherence or discharge care plan instructions. Additionally, transitions
of care in the outpatient setting to new adult-based practitioners may complicate hospital discharge
plans, including contingency plans for problems that could arise. These hospital discharge
experiences may vary by the type of CCD experienced by AYA. For example, AYA with CCDs that can
rapidly worsen in severity with insufficient care management (eg, ketoacidosis with type 1 diabetes)
may be more apt to follow through with discharge plans.
Emerging evidence suggests that age is a prominent risk factor associated with the odds of
unplanned hospital readmission in AYA. One prior study6 reported a substantial increase in the odds
of readmission for US adolescents as they aged into adulthood; their odds approximate the odds of
readmission among elderly Medicare beneficiaries. As nationwide interest in reducing readmissions
extends beyond elderly individuals, AYA—especially those with CCD—are an important, vulnerable
population of hospitalized patients who deserve further attention.7-10 Therefore, we conducted the
current national study to improve knowledge about hospitalized AYA who have a CCD and their
readmissions during their transition to adulthood. For AYA aged 15 to 30 years, we assessed variation
in the likelihood of readmission with increasing age and across different CCDs. We hypothesized that
the likelihood of readmission would increase with increasing age and would vary significantly
across CCDs.

Methods
Study Design and Setting
This is a retrospective 1-year cohort analysis of the 2014 Agency for Healthcare Research and Quality
(AHRQ) Nationwide Readmissions Database (NRD), a database of all-payer hospital inpatient stays
for patients of all ages. The NRD is drawn from 22 AHRQ State Inpatient Databases with variation in
size and population density. The NRD contains verified patient identifiers to link individuals across
hospitalizations. The 2014 NRD includes 14.9 million acute-care hospitalizations from 2048
hospitals, representing 35.3 million weighted total hospitalizations nationwide. This study,
performed with a waiver of informed consent, was not considered human subjects research by the
institutional review board at Boston Children’s Hospital because all data were deidentified.
Presentation and discussion of study findings follow Strengthening the Reporting of Observational
Studies in Epidemiology (STROBE) reporting guideline.
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Study Population
Index admissions (defined as any admission during the study period with 30-day eligibility for
readmission measurement after discharge) for individuals aged 15 to 30 years at admission with
cystic fibrosis, type 1 diabetes, IBD, spina bifida, and/or sickle cell anemia between January 1, 2014,
and December 1, 2014, were identified using the AHRQ Chronic Condition Indicator and Clinical
Classification System.2,11 These 5 diseases were chosen for analysis because each represents a
distinct organ system, has associations with complex medical needs, and requires strong selfmanagement skills to optimize well-being. We used the AHRQ Chronic Condition Indicator and
Clinical Classification System International Classification of Diseases, Ninth Revision, Clinical
Modification (ICD-9-CM) codes to distinguish the chronic diseases included in our study cohort. Index
admission measurement ended on December 1, 2014, to allow for a full 30-day readmission period
following all discharges. All-condition index admissions (ie, admission for any reason) were measured
for individuals with the chronic diseases aside from admissions for pregnancy and childbirth, which
were excluded using Major Diagnostic Category 14. Guided by methods used by the Centers for
Medicare & Medicaid Services, we also excluded index admissions for patients who died, left against
medical advice, were transferred to another acute-care hospital, or had a principal diagnosis of
cancer (AHRQ Clinical Classification System groups 11-45).12,13

Main Outcome Measure
The main outcome measure was 30-day, unplanned, all-cause readmission to any hospital following
discharge from an index admission. Readmissions were defined using Centers for Medicare &
Medicaid Services methodology.13 Centers for Medicare & Medicaid Services excludes planned
readmissions using AHRQ’s Clinical Classification System, which uses principal ICD-9-CM diagnosis
and procedure codes to identify admissions that are considered planned or potentially planned (eg,
chemotherapy, labor and delivery).

Index Admission Demographic and Clinical Characteristics
We assessed sex, payer (Medicare, Medicaid, private, self-pay, no charge, and other), length of stay,
and discharge disposition (home with self-care, postacute care, home with home nursing services).
We assessed the reason for each index admission using 3M Health Information System’s All Patient
Refined Diagnosis Related Groups.14,15 We also assessed the quarter of the year for hospital
discharge, with January through March composing the first quarter; April through June, the second;
July through September, the third; and October through December, the fourth. Race/ethnicity was
not assessed because it was not included in the NRD.
To count and describe patients’ coexisting chronic conditions, we used the AHRQ Chronic
Condition Indicator,11 a tool that identifies conditions that are expected to last 12 months or longer
and meet 1 or both of the following criteria: (1) the condition places limitations on self-care,
independent living, and social interactions and (2) the condition results in the need for ongoing
intervention with medical products, services, and special equipment.

Hospital Characteristics
We assessed the teaching status and location of index and readmitting hospitals (metropolitan
teaching, metropolitan nonteaching, and nonmetropolitan) as available in the NRD. A hospital was
considered a teaching hospital if it had an American Medical Association–approved residency
program, was a member of the Council of Teaching Hospitals, or had a 0.25 or higher ratio of full-time
equivalent interns and residents to hospital beds. Metropolitan hospitals were those in small and
large metropolitan areas defined by the US Department of Agriculture Urban Influence Codes.16

Statistical Analysis
Using NRD weighting methods, we estimated the total number of index admissions and 30-day
unplanned readmissions for all individuals aged 15 to 30 years at admission with each of the 5 CCD
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cohorts. The weighing method estimates findings from the NRD sample (n = 2006 hospitals) to the
universe of all US hospitals and their discharges.17 We calculated discharge weights using
poststratification on the sample hospital characteristics (US Census region, urban or rural location,
teaching status, bed size, and hospital control) and patient’s sex and age. The target universe of
inpatient discharges across all hospitals in the United States was determined for each stratum
(defined by the hospital and patient characteristics listed) using AHRQ’s 47 State Inpatient
Databases, which include 95% of all US hospital discharges, and American Hospital Association
hospital discharge counts for hospitals not reported in the State Inpatient Databases. Within each
stratum, each NRD inpatient admission received a discharge weight that was equal to the total
number of US inpatient discharges it represented.
In bivariable analysis, comparisons of index admission characteristics between patients with
and without a readmission were made using χ2 tests for categorical variables and Wilcoxon rank sum
tests for continuous variables. In multivariable analysis, a logistic regression model was derived for
individuals with each chronic disease (5 total models) to estimate the adjusted odds of readmission
for age at admission using fixed effects to control for confounding variables known to influence the
odds of readmission, including the number of chronic conditions, sex, payer, length of stay, discharge
disposition, and hospital type.14,18-20 In the model, age was entered in 2-year increments with age 15
to 16 years as the reference. All analyses were performed using SAS statistical software version 9.4
(SAS Institute). Two-sided P values less than .001 were considered statistically significant owing to
the large sample size.

Results
Characteristics of the Study Population
There were 215 580 all-cause index admissions (115 982 [53.8%] female; median [interquartile range]
age, 24 [20-27] years) for individuals aged 15 to 30 years with cystic fibrosis (n = 15 213), type 1
diabetes (n = 86 853), IBD (n = 48 073), spina bifida (n = 7819), and sickle cell anemia (n = 57 622)
(Table 1). There was a female predominance for all chronic diseases; this finding persisted when
excluding admissions for pregnancy and childbirth. There was significant variation in Medicaid
enrollment across disease categories (27.1% for IBD, 33.1% for cystic fibrosis, 41.6% for type 1
diabetes, 47.7% for spina bifida, and 58.5% for sickle cell anemia).
Regarding clinical characteristics, most hospitalized individuals had multiple coexisting
conditions and many were assisted with medical technology (Table 2). The percentages of
hospitalized AYA with 4 or more coexisting conditions were 33.4% for IBD, 34.2% for sickle cell
anemia, 44.5% for diabetes, 65.2% for cystic fibrosis, and 74.2% for spina bifida. Among all 5 studied
diseases, depression was one of the most common coexisting conditions (18.8% for sickle cell
anemia, 21.0% for IBD, 24.0% for spina bifida, 28.4% for diabetes, and 34.2% for cystic fibrosis).
There was significant variation across diseases in the percentages of individuals with technology
assistance (3.1% of patients with sickle cell anemia; 5.0%, type 1 diabetes; 10.3%, IBD; 19.5%, cystic
fibrosis; and 53.4%, spina bifida).

Index Admissions
Exacerbation of the underlying chronic disease was the most common reason for index admission for
AYA with IBD (35.1%), sickle cell anemia (78.0%), diabetes (55.1%), and cystic fibrosis (60.9%).
Participants with spina bifida had more diverse reasons for index admission, the most common of
which was kidney and urinary tract infection (11.3%).

30-Day Unplanned Hospital Readmissions
Hospital readmission rates varied among the studied diseases (19.8% for IBD, 20.2% for cystic
fibrosis, 20.4% for spina bifida, 22.5% for diabetes, and 34.6% for sickle cell anemia) and increased
with increasing age (Figure 1). The smallest increase in readmission rate (31.3%) was observed with
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IBD (readmission rate, 17.1% at age 15 years to 21.8% at 30 years). The largest increase (138.7%)
occurred with cystic fibrosis (8.2% at age 15 years to 29.0% at 30 years) (Figure 1). Readmission rate
did not vary by season of discharge from the index admission.
Most reasons for the index hospitalization and readmission were directly related to the
underlying primary chronic disease (Table 3). For example, 73.2% of index hospitalizations and
60.9% of readmissions for AYA with cystic fibrosis were for a cystic fibrosis exacerbation. Most
readmissions (72.4%) occurred in the same hospital as the index admission. However, this
percentage varied by disease (15.6% of AYA who had cystic fibrosis were readmitted to a different
hospital compared with 23.8% with spina bifida, 24.3% with IBD, 25.6% with sickle cell anemia, and
29.1% with diabetes) (Table 3).

Multivariable Analysis of Patient Characteristics and 30-Day Unplanned
Hospital Readmission
After controlling for patients’ other demographic and clinical characteristics, use of public insurance
was associated with higher odds of readmission for all studied diseases; odds ratios (ORs) for
readmission in AYA with public vs other types of insurance ranged from 1.2 (95% CI, 1.0-1.3) for spina
bifida to 2.0 (95% CI, 1.9-2.1) for diabetes (eTable in the Supplement). For all diseases, higher odds
of readmission were associated with higher number of coexisting chronic conditions. For instance,
compared with AYA with cystic fibrosis and 1 coexisting chronic condition, the odds of readmission
were 6 times higher for AYA with more than 8 coexisting conditions (OR, 6.2; 95% CI, 4.6-8.5)
(eTable in the Supplement).
There was variation across diseases in the association between increasing age and the adjusted
odds of readmission (Figure 2). For example, the odds of readmission for AYA with cystic fibrosis

Table 1. Demographic and Hospitalization Characteristics of Individuals With Chronic Diseases Aged 15 to 30
Years at Admission
No. (%)
Characteristic

Type 1 Diabetes

Sickle Cell
Disease

Inflammatory
Bowel Disease

Cystic Fibrosis Spina Bifida

Hospitalizations, No.

96 030

77 593

52 157

15 531

8404

Age at admission,
median (IQR), y

23 (20-27)

24 (20-27)

24 (21-28)

22 (18-25)

23 (19-27)

Female

56 604 (58.9)

51 395 (66.2)

28 375 (54.4)

8562 (55.1)

5126 (61.0)

Demographic characteristics

Payer
Medicare

6868 (7.2)

11 219 (14.5)

2694 (5.2)

2010 (13.0)

1539 (18.4)

Medicaid

39 831 (41.6)

45 309 (58.5)

14 087 (27.1)

5114 (33.1)

4002 (47.7)

Private

32 092 (33.5)

15 200 (19.6)

28 799 (55.3)

7340 (47.5)

2440 (29.1)

Self-pay

11 666 (12.2)

2993 (3.9)

3495 (6.7)

267 (1.7)

150 (1.8)

No charge

1614 (1.7)

365 (0.5)

708 (1.4)

31 (0.2)

13 (0.2)

Other

3690 (3.9)

2324 (3.0)

2272 (4.4)

698 (4.5)

242 (2.9)

2 (2-4)

3 (2-6)

3 (2-6)

7 (4-13)

4 (2-7)

Urban, teaching

62 032 (64.6)

61 239 (78.9)

39 787 (76.3)

14 360 (92.5) 6653 (79.2)

Urban, nonteaching

23 545 (24.5)

12 887 (16.6)

9805 (18.8)

823 (5.3)

1214 (14.4)

Rural

10 453 (10.9)

3467 (4.5)

2566 (4.9)

348 (2.2)

537 (6.4)

In-hospital mortality

273 (0.3)

152 (0.2)

90 (0.2)

214 (1.3)

85 (1.0)

Routine to home

90 783 (94.6)

75 336 (97.1)

47 812 (91.7)

12 356 (79.6) 6439 (76.6)

Hospitalization
characteristics
Length of stay,
median (IQR), d
Type of index hospital

Discharge disposition

Home health care

3644 (3.8)

1725 (2.2)

3826 (7.3)

3042 (19.6)

1425 (16.9)

Postacute care

1552 (1.6)

481 (0.6)

476 (0.9)

132 (0.8)

542 (6.4)
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were nearly 2 times higher (OR, 1.9; 95% CI, 1.6-2.3) for individuals aged 29 to 30 years vs 15 to 16
years. In contrast, only modest changes were observed in the odds of readmission for AYA ages 29 to
30 years vs 15 to 16 years with IBD (OR, 1.2; 95% CI, 1.0-1.3) and spina bifida (OR, 1.3; 95% CI, 1.1-1.7).
For diabetes and sickle cell anemia, the adjusted odds of readmission peaked at ages 23 years (OR,
2.3; 95% CI, 2.1-2.6) and 26 years (OR, 2.0; 95% CI, 1.9-2.2), respectively. Unique among CCDs
studied, patients with diabetes demonstrated an initial increase and subsequent decrease in the
adjusted odds of readmission between ages 15 and 30 years (Figure 2).

Discussion
This article describes the characteristics of hospitalized AYA who have a CCD and shows that this
population experienced high rates of 30-day unplanned hospital readmission that increased with
age. The hospitalized population of AYA who have CCDs is remarkable for its female predominance

Table 2. Clinical Characteristics of Hospitalized Individuals With Chronic Diseases Aged 15 to 30 Years
at Admission
No. (%)
Characteristic

Type 1 Diabetes

Sickle Cell
Disease

Inflammatory
Bowel Disease

Cystic Fibrosis

Hospitalizations, No.

96 030

77 593

52 157

15 531

8404

Technology assistancea

4772 (5.0)

2407 (3.1)

5372 (10.3)

3035 (19.5)

4486 (53.4)

2-3

39 429 (41.1)

41 684 (53.7)

22 985 (44.1)

4542 (29.2)

1938 (23.1)

4-5

23 639 (24.6)

16 083 (20.7)

10 615 (20.4)

5155 (33.2)

2419 (28.8)

6-7

10 796 (11.2)

5025 (6.5)

4027 (7.7)

2956 (19)

1742 (20.7)

8-9

4577 (4.8)

1469 (1.9)

1457 (2.8)

1304 (8.4)

1007 (12)

≥10

2660 (2.8)

714 (0.9)

512 (1.0)

616 (4.0)

810 (9.6)

Depression
(26.9)c

Asthma (26.7)

Anxiety (22.7)c

Type 2 diabetes Neurogenic
(52.0)
bladder (52.1)

Chronic pain
(22.6)

Depression
(20.2)c

Esophageal
reflux (42.6)

Shunted
hydrocephalus
(41.7)

Spina Bifida

Chronic conditions,
No.b

Most common
coexisting chronic
conditions (%)b
No. 1

c

No. 2

Anxiety (20.9)

No. 3

Hypertension
(19.8)

Aseptic necrosis
hip (16.4)

Esophageal reflux
(15.6)

Depression
(33.8)c

Decubitus ulcer
(25.2)

No. 4

Substance abuse
(19.0)c

Depression
(15.6)c

Asthma (12.0)

Malnutrition
(28.9)

Paraplegia
(24.2)

No. 5

Peripheral nerve
disorder (17.4)

Hemochromatosis Chronic pain
(13.9)
(11.7)

Anxiety (27.4)c

Depression
(23.0)c

a

Technology assistance includes use of items such as
gastrostomy, tracheostomy, cerebrospinal fluid
shunt, insulin pump, and renal dialysis catheter.

b

Chronic conditions were distinguishing using the
Agency for Healthcare Research and Quality Chronic
Condition Indicator and Clinical
Classification System.

c

Indicates coexisting conditions related to mental
health and substance abuse.

Figure 1. Trends in Unadjusted, 30-Day, Unplanned All-Cause Readmission Rates by Age at Admission
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35
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and its prevalence of comorbid conditions, particularly mental health diagnoses. Of the CCDs studied
here, AYA who have sickle cell anemia had the highest unadjusted readmission rates. Adolescents
and young adults who have cystic fibrosis experienced the largest increase in the adjusted odds of
hospital readmission with increasing age. In contrast, AYA who have diabetes experienced an
increase in the odds of readmission—peaking at 23 years—and a subsequent decrease with age.
Across all CCDs, public insurance and multiple coexisting conditions were associated with higher
odds of readmission.
Regarding patient characteristics, hospitalized AYA who have CCDs were predominantly female,
with female patients accounting for three-fifths of admissions. Prior studies21-25 also report a

Table 3. Characteristics of 30-Day Unplanned Hospital Readmission for Individuals With Chronic Diseases Aged 15 to 30 Years at Index Admission
No. (%)
Characteristic

Type 1 Diabetes

Sickle Cell
Disease

Inflammatory
Bowel Disease

Cystic Fibrosis

Spina Bifida

30-d unplanned
readmission rate, %

22.5

34.6

19.8

20.2

20.4

1

6907 (64.5)

4554 (53.4)

4869 (72.5)

951 (59.0)

719 (70.4)

2

1803 (16.8)

1630 (19.1)

1189 (17.7)

342 (21.2)

175 (17.2)

≥3

1998 (18.7)

2340 (27.5)

661 (9.8)

319 (19.8)

127 (12.5)

12 (5-20)

14 (6-22)

11 (5-19)

15 (8-22)

12 (6-21)

Readmissions to different 29.1
hospital, %

25.6

24.3

15.6

23.8

In-hospital mortality

76 (0.4)

73 (0.3)

44 (0.4)

82 (2.6)

14 (0.9)

No. 1

Diabetes (55.1)

Sickle cell anemia crisis (78)

Inflammatory bowel
disease (35.1)

Cystic fibrosis (60.9)

Kidney and urinary tract
infections (15.2)

No. 2

Peripheral, cranial and
autonomic nerve disorders
(9.8)

Other anemia and disorders
of blood and blood-forming
organs (2.5)

Major small and large
bowel procedures (8.6)

Septicemia and disseminated
Septicemia and
disseminated infections infections (9)
(4.8)

No. 3

Septicemia and
disseminated infections
(2.8)

Pneumonia (1.6)

Major gastrointestinal and
peritoneal infections (4.8)

Pancreatic disorder
(3.8)

Malfunction, reaction, and
complications of genitourinary
device or procedure (5.1)

No. 4

Renal failure (2)

Septicemia and disseminated
infections (1.5)

Intestinal obstruction
(3.5)

Other digestive system
diagnoses (2.2)

Ventricular shunt procedures
(4.3)

No. 5

Pancreatic disorder (1.4)

Postoperative, posttraumatic, Septicemia and
disseminated infections
and other device infections
(3.2)
(1.1)

Intestinal obstruction
(2)

Postoperative, posttraumatic,
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predominance of female admissions across the CCDs studied. Sex differences in incidence of the
studied CCDs do not explain this finding. For example, type 1 diabetes has a male predominance of
indicence.26 Reproductive health care needs might be hypothesized to help explain this finding.
However, admissions for pregnancy and childbirth were excluded from our analysis. Although not
assessed in the current study, the female predominance in hospitalization may be related to prior
investigations that show potential differences in self-management (eg, medication
management),27,28 use of outpatient care (eg, for chronic disease management),29,30 disparate
severity of disease (eg, earlier mortality in women with cystic fibrosis),22,31 and perceptions of
symptoms that influence the decision to seek and provide inpatient care.32 Further investigation is
thus needed to understand the causes and significance of the sex differences in hospital use for AYA
who have CCDs.
In addition to the finding on sex, our study revealed a high prevalence of coexisting conditions
in hospitalized AYA who have a CCD. Increased number of coexisting conditions was associated with
higher odds of readmission. Because our cohort comprised hospitalized patients only, the high
prevalence of the conditions may indicate a selection of high-risk patients with a more severe
phenotype of disease. Many coexisting conditions were related to the pathophysiology of the
underlying CCD. For example, patients with sickle cell anemia had a high prevalence of aseptic
necrosis of the hip and patients with cystic fibrosis had a high prevalence of type 2 diabetes. Those
types of coexisting conditions increase the complexity of care requirements (eg, additional
monitoring, therapeutics). Thus, multimorbidity may represent an important crosscutting phenotype
of AYA who have CCDs to target for high-quality discharge planning.
Relatedly, our study also found a high prevalence of depression in hospitalized AYA who have
CCDs. Mental health diagnoses may compound the difficulty of CCD management by impairing
patients’ abilities to adhere to discharge treatment plans. For example, in patients with type 1
diabetes, depression is associated with higher values of glycated hemoglobin.33 Prior studies also
report an association between reduced lung function and depression in individuals with cystic
fibrosis.12,30,34,35 Depression has also been associated with impaired disease control for IBD.36 It
remains difficult to distinguish whether coexisting depression leads to worsened health or whether
depression develops as a result of worsened health.37 Regardless, emerging mental health
interventions for individuals with chronic disease show promise to optimize disease control.36,38 For
example, intensive psychotherapy has been shown to decrease admissions for diabetic ketoacidosis
in patients with diabetes.38 Insufficient access to and inconsistent use of these interventions
complicate this proposition, especially during discharge planning.39,40 Therefore, the presence of a
mental health diagnosis may be another indicator of the need for enhanced discharge planning for
AYA who have a CCD.
Nearly one-fourth of hospitalized AYA who have a CCD in the current study experienced 30-day
hospital readmission. This rate is 3-fold higher than the general population in this age group and also
higher than Medicare beneficiaries older than 65 years.6 Among the AYA in the current study, those
with sickle cell anemia demonstrated the highest 30-day readmission rate (28.1%). This high rate is
consistent with prior studies; several attributes may explain it.15,41,42 Exacerbations of sickle cell
anemia (eg, vaso-occlusive episodes) have high morbidity and often a rapid onset with severe health
deterioration.15,43 Moreover, individuals with sickle cell anemia commonly have chronic exposures
to pain medications, including opioids. These issues complicate intervention and management of
sickle cell anemia exacerbations in the ambulatory setting. In addition, as we observed, individuals
with sickle cell anemia use public insurance more than young adults with other CCDs. Adolescents
and young adults with public insurance may also have social and financial challenges that could affect
access to high-quality outpatient preventive and urgent care.44,45 The emergence of effective
interventions to prevent and manage sickle cell episodes (eg, hydroxyurea and sickle cell day
treatment programs) call attention to the need for safe discharge of hospitalized individuals with
sickle cell anemia.
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The contrasting trends in adjusted odds of readmissions with increasing age for AYA who have
cystic fibrosis and diabetes merit discussion. While odds of readmission increased for patients with
cystic fibrosis with increasing age, a similar initial increase in odds for patients with diabetes with
increasing age was followed with a decrease as patients approached age 30 years. This difference is
surprising and its cause is not obvious. Care management for both diseases is routinely associated
with receipt of time-sensitive medications, use of durable medical equipment, and interpretation of
laboratory and testing results (eg, blood glucose for diabetes; peak expiratory flow for cystic
fibrosis), all of which may be required multiple times per day.46,47 Although the current study was not
positioned to assess self-management of chronic disease, it is possible that increases in autonomy
for AYA could have contributed to variable adherence to management strategies following discharge,
resulting in increased likelihood of readmission during the adolescent years and early 20s.38,48-50
Relatedly, we speculate that the decrease in odds of readmission for AYA with diabetes from age 23
to 30 years could potentially reflect gains in self-management skills that stabilized and controlled
diabetes severity. In contrast, hospitalized AYA with cystic fibrosis may have experienced increasing
severity of disease with increasing age despite their best self-management efforts, which led to a
steady increase in odds of readmission. Further investigation is necessary to assess those
speculations—including how they might generalize to other CCDs—and how much emerging
transition program interventions can help optimize self-care practices and stabilize health for AYA
who have cystic fibrosis, in particular, soon after discharge.34,46

Limitations
This study has several limitations. The cross-sectional design cannot make inferences about the
health trajectory of individual AYAs as their ages increased from 15 to 30 years. Limitations also
include data not available in the NRD. We were unable to assess a full calendar year of index
admissions because January 30-day readmissions for December index admissions are not available
in the database. Data on readmissions to hospitals in a different US state from the index admission
hospital are not available in the NRD. Furthermore, the NRD does not contain data about
characteristics such as functional status, self-management, social and familial issues, outpatient
health care use, quality of life, and other characteristics associated with hospital readmissions. In
addition, the NRD does not contain information on reason for insurance enrollment. Therefore, we
were unable, for example, to assess how much Medicare enrollment in AYA was due to end-stage
renal disease vs other enrollment qualifications (eg, being an adult dependent of a Medicare
beneficiary).51,52
Reliance on diagnostic coding created additional limitations. The inpatient diagnosis billing
codes did not convey information about the severity of the coexisting chronic conditions.
Furthermore, it is possible that some conditions may be undercoded in the inpatient setting. The
NRD does not contain data on inpatient clinicians, including their training and field. Therefore, we
could neither cluster data by clinician nor assess whether pediatric or adult practitioners discharged
the AYA.

Conclusions
The examinations from the current study underscore the vulnerability of health after discharge for
AYA who have a CCD. Adolescents and young adults who have a CCD have 30-day unplanned hospital
readmission rates that increase with age and that are 3 times higher than the general population of
AYA. Increased attention to hospital readmissions in AYA who have a CCD is necessary to optimize
their health and safety at hospital discharge. Future studies should assess how self-management of
CCD and transfer of care to adult health care practitioners influences the likelihood of hospital
readmission. Future investigations might also include CCDs beyond the 5 we selected such that
overarching trends in readmission rates across age can be identified.
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In the interim, hospital and outpatient practitioners may find the results from the current study
useful during discharge planning. Helping AYA who have a CCD understand the elevated risk of
hospital readmission and how this risk increases with age may be important. Paying particular
attention to processes of discharge care that AYA might experience differently in context of pediatric
vs adult care may be important; examples of such processes include (1) assessing readiness for
hospital discharge, (2) creating contingency plans for problems that might arise after discharge, and
(3) making appointments for follow-up with outpatient and community practitioners after discharge.
Those discharge care activities might be especially pertinent for particular types of AYA, including
those with multimorbidity and mental health diagnoses.
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